AUGUST 2006



REVIEW ARTICLE

A literature review of the connection between dioxin exposure and endometriosis

Eduardo Schor
Head, Pelvic Pain and Endometriosis Unit, Universade Federal de Sao Paulo, Brazil

 

Introduction
Despite the numerous papers published over the last decades, pathogenesis of this enigmatic disease, called endometriosis, still remains obscure. Immune alterations, disorders of the topical endometrium and genetic disposition have all been associated with the genesis of the disease.

At present we seem to observe an increasing prevalence, in addition to a greater aggressiveness of endometriosis, and thus a probable involvement of environmental factors has been hypothesised.

Dioxins are a group of environmental pollutants consisting mainly of PCDF, PCB and PCDD. Among PCDDs 2,3,7,8-tetrachorodibenzo-p-dioxin (TCDD), usually known as dioxin, one of the most potent pollutants, is to be noted, and there is evidence suggesting that this compound may be related to endometriosis (for additional information on dioxin see www.ejnet.org/dioxin/).

Dioxin is a universal pollutant, derived mainly from incineration of garbage and metal processing. Because it is lipophilic it is retained in the food chain and common foods are the main source of dioxin exposure for humans.

TCDD, an endocrine disruptor, may lead to endometriosis mainly through genomic mechanisms, however, non-genomic actions have been reported. Its action on DNA, as well as on sexual steroid synthesis and metabolism, may lead to alterations which formerly had already been related to endometriosis.

Mechanisms of action of dioxin
Dioxin activity in the body is by binding to the aryl hydrocarbon receptor after which the compound is carried to the nucleus by the AHR nuclear translocator (ARNT) where it will bind to the dioxin responsive element activating the transcription of a series of genes [1].

One of the principal defense mechanisms of the body against the xenobiotic is activation of genes that code for detoxification enzymes, mainly those of the first phase with emphasis on the Cyp family, especially Cyp 1A1 and Cyp 1B1 [2].

Numerous genes, responsible for the transcription of pro-inflammatory cytokines, are activated after exposure to dioxin and among which RANTES, IL-5, IL-6, IL-7, IL-9, IL-10 and IL-1beta, TNF-alpha should be mentioned. The vascular endothelial growth factor (VEGF), which is known to be involved in the pathophysiology of endometriosis, has also its transcription activated by dioxin. Binding of ARNT to DNA also leads to activation of transcription of genes responsible for oestradiol synthesis besides, possibly, altering splicing in the transcription of the gene responsible for coding for progesterone receptors [3,4,5].

Dioxin and endometriosis
In view of the evidence that dioxin could be involved in oestrogen-dependent diseases, some authors evaluated the association of this pollutant with the disease. Rier et al, in 1993 [6], evaluated the prevalence of endometriosis in female rhesus monkeys exposed to dioxin for 10 years. The authors observed a significant and dose-dependent increase in the prevalence of moderate and severe endometriosis in animals exposed to the pollutant. On studying cynomolgus monkeys, Yang et al [7] reported, in addition to persistence of lesions, an increase in their diameter after exposure to TCDD when compared to non-exposed animals.

In humans, population studies in Seveso, Italy, and in Belgium, at sites where there was exposure of the population to high doses of the pollutant because of industrial accidents, failed to identify the relationship between an increase in serum dioxin concentration and the prevalence of endometriosis. However, due to the fact that dioxin accumulates in fatty tissues, serum measurement would not be the ideal means to estimate dioxin concentration present in the body.

Reviewing the literature, Arisawa et al concluded that there is no evidence up to now supporting the hypothesis of a relationship between the disease and exposure to dioxin but emphasize the need for population studies of high statistical power in order to be able to evaluate this association [8].

Role of dioxin in the pathogenesis of endometriosis
Studies on the pathogenesis of endometriosis report alterations in the topical endometrium. Disturbances of the cell cycle, either increase in proliferation or decrease in apoptosis, have already been reported. Increase in matrix metalloproteinase expression, as well as decrease in TIMP, favour implantation of this endometrium in the peritoneal surface. After implantation, formerly described increase in VEGF is responsible for neo-angiogenesis.

All these alterations favour implantation of endometrial cells in an inhospitable environment: the peritoneum [9].

On looking for a single alteration which leads to all these disturbances it was discovered that progesterone regulates, either directly or indirectly, their expression in the topical endometrial cells, presupposing that a deficiency in the action of this hormone could be involved in the genesis of endometriosis.

Progesterone acts on two different receptors coded for by the same gene, PRA and PRB, and an adequate proportion between both is fundamental for the correct action of progesterone on the endometrium. The known anti-oestrogenic action of progesterone is mediated by the type B receptor; when there is an increase in PRA or a decrease in PRB, we could have an oestrogen-like action, favouring the emergence of endometriosis. Igarashi et al recently reported a decrease in the PRB/PRA ratio in cultured topical endometrial cells of women with endometriosis after exposure to dioxin, suggesting that alteration in progesterone action and consequently the previously reported disturbances in the topical endometrium of women with endometriosis would be due to exposure to TCDD [10].

In addition to the endometrial alterations, dioxin acts by increasing the expression of detoxification enzymes. Increase in the expression of the Cyp family enzymes, mainly Cyp 1A1, leads to a paradoxical effect; this enzyme metabolises oestrogens to catechol-oestrogens, generating a strongly oestrogenic environment, contributing to the pathophysiology of the disease. Finally, several immune alterations in the peritoneal environment of patients with endometriosis, either in the humeral or in the cellular compartment, have already been described, alterations that are necessary for the endometrial cell which reaches the pelvic cavity not to be removed. Dioxin acts on a series of components of the immune system; we may point out the decrease of NK cell action, in addition to stimulation of secretion of pro-inflammatory cytokines such as IL-5, IL-6, IL-9 and RANTES.

Alterations promoted by exposure to this environmental potent pollutant could lead to disorders of the topical endometrial cells, a hyper-oestrogenic environment and immune alterations which all together would lead to the emergence of endometriosis.

Genetic polymorphisms
In the beginning of the 1980s of the last century some studies described that retrograde menstruation occurred in approximately 80% of women, thus showing that the theory of retrograde menstruation proposed by Sampson did not explain alone the genesis of the disease; the same occurring with the environmental theory. Dioxin is an ubiquitous pollutant and all women, in a same environment, are exposed to the same dioxin concentration. What is the reason why only a part of them develops the disease?

This fact is justified by genetic polymorphisms which are small DNA alterations that in the presence of an external stimulus generate phenotypic alterations. Diverse polymorphisms have already been studied in women with endometriosis, among which detoxification enzymes of the first and second phases are to be pointed out as concerns dioxin. Up to the present the results were inconclusive. In a review of the literature, Guo analyzed studies on polymorphism of Cyp 1A1 and 1B1 first phase enzymes, GSTM of the second phase and reached the conclusion that new population studies are required to define if there is or not alteration of the genes coding for detoxification enzymes in women with endometriosis [11].

Conclusion
The actual role of dioxins in the pathogenesis of endometriosis is still being discussed and evidence suggests that endometrial, immune alterations may originate from exposure to this xenobiotic. Genetic alteration, probably the polymorphisms, would be the cause of the disease’s emergence in only a part of the exposed women, however further studies on these alterations in genes that code for detoxifying proteins are still needed.

The search for pathogenetic mechanisms of endometriosis should be unremitting since the elucidation of the mysteries of this enigmatic disease is mandatory for the improvement of therapy as well as primary prevention.

REFERENCES

1. Mandal PK. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol 2005;175(4):221-30.

2. Pocar P, Fischer B, Klonish T, Hombach-Klonish S. Molecular Interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 2005;129(4):379-89.

3. Zhao D, Pritts EA, Chao VA, Savouret JF, Taylor RN. Dioxin stimulates RANTES expression in an in vitro model of endometriosis. Mol Hum Reprod 2002;8(9):849-54.

4. Rier S, Foster WG .Environmental dioxins and endometriosis. Toxicol Sci 2002;70(2):161-70.

5. Rier S, Foster WG Environmental dioxins and endometriosis. Semin Reprod Med 2003;21(2):145-54.

6. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993;21(4):433-41.

7. Yang JZ, Agarwal SK, Foster WG. Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol Sci 2000;56(2):374-81.

8. Arisawa K, Takeda H, Mikasa H. Background exposure to PCDDs/PCDFs/PCBs and its potential health effects: a review of epidemiologic studies.J Med Invest 2005;52(1-2):10-21.

9. Giudice LC,Kao LC.Endometriosis. Lancet 2004;13-19;364(9447):1789-99.

10. Igarashi TM, Bruner-Tran Kl, Yeaman GR, Lessey BA, Edwards DP, Eisenberg E, Osteen KG. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril 2005;84(1):67-74.

11. Guo SW. The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a systematic review. Eur J Obstet Gynecol Reprod Biol 2006;124(2):134-43.

Next...

 

Contents

Professor Ali Akoum
Editor WES e-journal
Faculty of Medicine
Laval University Research Centre
St-Francis of Assisi Hospital
DO-708B, 10 Rue de L'Espinay
Québec, GIL 3L5, Canada

ali.akoum@crsfa.ulaval.ca

 

 
© World Endometriosis Society 1998-2008